UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): | July 17, 2006 |
Lifeline Therapeutics, Inc.
__________________________________________
(Exact name of registrant as specified in its charter)
Colorado | 000-30489 | 84-1097796 |
_____________________ (State or other jurisdiction |
_____________ (Commission |
______________ (I.R.S. Employer |
of incorporation) | File Number) | Identification No.) |
6400 S. Fiddler's Green Circle, Suite 1970, Englewood, Colorado | 80111 | |
_________________________________ (Address of principal executive offices) |
___________ (Zip Code) |
Registrants telephone number, including area code: | 720-488-1711 |
Not Applicable
______________________________________________
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 7.01 Regulation FD Disclosure.
On July 17, 2006, Lifeline Therapeutics, Inc. issued a press release entitled "Lifeline Therapeutics, Inc. Announces Distribution of Protandim in CVS/pharmacy Stores Nationwide". The press release is attached as Exhibit 99.1 hereto.
Item 9.01 Financial Statements and Exhibits.
Press release dated July 17, 2006, entitled "Lifeline Therapeutics, Inc. Announces Distribution of Protandim in CVS/pharmacy Stores Nationwide".
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Lifeline Therapeutics, Inc. | ||||
July 19, 2006 | By: |
Stephen K. Onody
|
||
|
||||
Name: Stephen K. Onody | ||||
Title: CEO |
Exhibit Index
Exhibit No. | Description | |
|
|
|
99.1
|
Press release dated July 17, 2006, entitled "Lifeline Therapeutics, Inc. Announces Distribution of Protandim in CVS/pharmacy Stores Nationwide". |